Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Leptin receptor (LEPR) is a type I cytokine receptor that plays a pivotal role in the regulation of body weight and energy expenditure by mediating the effects of the hormone leptin (UniProt P48357). While its function in the hypothalamus is well-documented for controlling satiety, LEPR is also significantly expressed in oral sensory neurons, particularly within the taste receptor cells of the tongue (Shigemura et al., 2004, PubMed: 15513991). In these peripheral neurons, leptin functions as a specific modulator of taste, selectively suppressing the neural and behavioral responses to sweet stimuli without affecting other taste modalities (Kawai et al., 2000, PubMed: 11004354). This suppression is achieved through the activation of ATP-sensitive potassium (KATP) channels, which hyperpolarizes sweet-sensitive taste cells and decreases their excitability. Consequently, the leptin receptor in the oral cavity acts as a metabolic sensor that adjusts taste sensitivity based on the body's energy status, and its dysfunction is implicated in the development of obesity and altered eating behaviors (Niki et al., 2011, PubMed: 21673049). Therapeutic interventions targeting this receptor, such as metreleptin, are currently utilized for rare metabolic disorders, but the oral LEPR pathway remains a target of interest for broader applications in appetite control and obesity management.
Agonism of the leptin receptor (LEPR) activates the JAK2/STAT3 signaling pathway; specifically in oral sensory neurons, LEPR activation leads to the opening of ATP-sensitive potassium (KATP) channels, which hyperpolarizes sweet-responsive taste cells and reduces their sensitivity to sweet stimuli (Kawai et al., 2000; Shigemura et al., 2004).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leptin receptor (LEPR) (LEPR).